Contrast Echocardiography Remains Positive After Treatment of Pulmonary Arteriovenous Malformations*
- 1 February 2003
- journal article
- Published by Elsevier BV in Chest
- Vol. 123 (2), 351-358
- https://doi.org/10.1378/chest.123.2.351
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Rare diseases bullet 4: Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanismsThorax, 1999
- Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2Nature Genetics, 1996
- Hereditary Hemorrhagic TelangiectasiaNew England Journal of Medicine, 1995
- Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients.Thorax, 1995
- Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nature Genetics, 1994
- Hereditary hemorrhagic telangiectasia: A disorder in search of the genetics communityAmerican Journal of Medical Genetics, 1994
- Two-dimensional contrast echocardiography in the detection and follow-up of congenital pulmonary arteriovenous malformationsThe American Journal of Cardiology, 1991
- Comparison of transesophageal and transthoracic contrast echocardiography for detection of a patent foramen ovaleThe American Journal of Cardiology, 1991
- Detection and exclusion of interatrial shunts by two-dimensional echocardiography and peripheral venous injection.Circulation, 1979
- A nomogram for venous shunt (QS/QT) calculationThorax, 1968